Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

disease progression

- PMLiVE

Merck KGaA appoints new chief information officer

Promotes the head of its strategy realisation office James Stewart

- PMLiVE

VIDEO: The impact of new technology on healthcare

Mindy Daeschner, director of PSHealth, explains how technology needs to be part of any discussion on the value of treatment

- PMLiVE

Currencies hit Merck Serono sales but firm says it is ‘on course’

Overall groups sales down to €2.84bn for second quarter of 2013

Biogen Idec building

Biogen Idec signs brain research deal with Edinburgh University

Will identify potential treatments for multiple sclerosis and motor neurone disease

- PMLiVE

Merck Serono pushes into immunotherapies for cancer

Pharma company sets up dedicated R&D unit

- PMLiVE

European Commission hails progress on paediatric medicines

Says improvements made on both safety and research in Europe

EU flag

Nine pharma firms face EU fines over pay-for-delay deals

Lundbeck could be the hardest hit with a maximum penalty of €240m

- PMLiVE

Merck KGaA to research cancer drug with Chinese biotech

German pharma firm teams up with BeiGene on BRAF inhibitor

- PMLiVE

Gilead launches combination HIV pill in UK and Germany

Stribild is approved in EU as once-daily single tablet

- PMLiVE

Merck KGaA forges clinical alliance with Quintiles

CRO becomes sole outsourcing partner for pharma company

- PMLiVE

Merck KGaA to meet 2014 financial targets one year early

But continued growth of Rebif under threat from new oral MS drugs

- PMLiVE

Future imperfect: How breakthrough technology can support healthcare

Current economic strategies are fundamentally flawed and the age of plenty is coming to an end, according one self-professed futurist. Could breakthrough technologies save humankind from a sticky end?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links